{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:13:40Z","timestamp":1791828820834,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction and Hypothesis<\/jats:title>\n                    <jats:p>Energy-based devices (EBDs), including vaginal laser and radiofrequency therapies, have been proposed as minimally invasive treatments for stress urinary incontinence (SUI), but evidence remains limited and inconsistent. We hypothesised that EBDs would provide greater symptom improvement than sham, particularly in women with mild to moderate SUI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following PRISMA guidelines, we searched Medline, Embase, the Cochrane Library, and One Search for randomised controlled trials (RCTs) comparing EBDs with sham in women with SUI, with at least 1 month of follow-up. The primary outcome was change in International Consultation on Incontinence Questionnaire\u2013Urinary Incontinence Short Form (ICIQ-UI SF) scores. Two reviewers independently performed data extraction and RoB-2 assessment. Random-effects meta-analyses using restricted maximum likelihood estimation were conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ten RCTs (11 datasets; ~ 850 women) were included. Using a random-effects model with Knapp\u2013Hartung adjustment, the pooled EBD analysis showed a mean difference of \u20131.08 points (95% CI \u20132.08 to \u20130.08), indicating a statistically significant improvement with EBD. The prediction interval (\u20133.63 to 1.48) suggests a wide range of possible effects, including no benefit. Heterogeneity was moderate (I\n                      <jats:sup>2<\/jats:sup>\n                      = 53%). Subgroup analysis of non-ablative Er:YAG laser showed the strongest and most homogeneous effect (MD \u20131.42; 95% CI \u20132.55 to \u20130.28; I\n                      <jats:sup>2<\/jats:sup>\n                      = 29%). CO\n                      <jats:sub>2<\/jats:sub>\n                      laser findings were inconsistent, and evidence for radiofrequency was insufficient. Adverse events were mild and transient.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>EBDs may improve SUI symptoms compared with sham, with the most consistent benefit observed for non-ablative Er:YAG laser. However, effects are modest and short-term. High-quality RCTs with standardised protocols and long-term follow-up are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00192-026-06604-9","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:47:14Z","timestamp":1773917234000},"page":"2779-2790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Use of Energy-Based Devices for the Treatment of Stress Urinary Incontinence: A Systematic Review and Meta Analysis of the Randomised Sham-Controlled Trials"],"prefix":"10.1007","volume":"37","author":[{"given":"David","family":"Lukanovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetika","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miha","family":"Matja\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"5","key":"6604_CR1","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/bju.14927","volume":"125","author":"RD Sussman","year":"2020","unstructured":"Sussman RD, Syan R, Brucker BM. Guideline of guidelines: urinary incontinence in women. BJU Int. 2020;125(5):638\u201355.","journal-title":"BJU Int"},{"issue":"1","key":"6604_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37\u201349.","journal-title":"Urology"},{"key":"6604_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejogrb.2020.03.034","volume":"251","author":"C Phillips","year":"2020","unstructured":"Phillips C, Hillard T, Salvatore S, Toozs-Hobson P, Cardozo L. Lasers in gynaecology. Eur J Obstet Gynecol Reprod Biol. 2020;251:146\u201355.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"6604_CR4","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.juro.2011.06.054","volume":"186","author":"B Chen","year":"2011","unstructured":"Chen B, Yeh J. Alterations in connective tissue metabolism in stress incontinence and prolapse. J Urol. 2011;186(5):1768\u201372.","journal-title":"J Urol"},{"key":"6604_CR5","unstructured":"National Institute for Health and Care Excellence (NICE). Urinary incontinence and pelvic organ prolapse in women: management. NICE guideline NG123; 2019. Available from: https:\/\/www.nice.org.uk\/guidance\/ng123\/resources\/urinary-incontinence-and-pelvic-organ-prolapse-in-women-management-pdf-66141657205189"},{"key":"6604_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejogrb.2023.05.014","volume":"286","author":"GS Shah","year":"2023","unstructured":"Shah GS, Phillips C. What women want now! Eur J Obstet Gynecol Reprod Biol. 2023;286:118\u201320.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"6604_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/13697137.2017.1366749","volume":"20","author":"TC Hillard","year":"2017","unstructured":"Hillard TC. Turning the spotlight on lasers. Climacteric. 2017;20(5):397\u20139.","journal-title":"Climacteric"},{"issue":"4","key":"6604_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/tog.12605","volume":"21","author":"S Jha","year":"2019","unstructured":"Jha S, Hillard T. Energy devices in vaginal therapy. Obstet Gynaecol. 2019;21(4):233\u20136.","journal-title":"Obstet Gynaecol"},{"key":"6604_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013643.pub2","author":"GM Ippolito","year":"2025","unstructured":"Ippolito GM, Crescenze IM, Sitto H, Palanjian RR, Raza D, Barboglio Romo P, et al. Vaginal lasers for treating stress urinary incontinence in women. Cochrane Database Syst Rev. 2025. https:\/\/doi.org\/10.1002\/14651858.CD013643.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"6604_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/lsm.70012","volume":"57","author":"H Yan","year":"2025","unstructured":"Yan H, Wang J, Ding Y, Huang G, Ding H, Zhao W, et al. The efficacy and safety of erbium-doped yttrium aluminum garnet laser therapy for stress urinary incontinence: a systematic review and meta-analysis. Lasers Surg Med. 2025;57(4):297\u2013305. https:\/\/doi.org\/10.1002\/lsm.70012.","journal-title":"Lasers Surg Med"},{"issue":"2","key":"6604_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00345-022-04247-1","volume":"41","author":"C Zhang","year":"2023","unstructured":"Zhang C, Chen Y, Liu S, Chen J, Shen H, Luo D. Effect of vaginal energy-based treatment on female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials. World J Urol. 2023;41(2):405\u201311. https:\/\/doi.org\/10.1007\/s00345-022-04247-1.","journal-title":"World J Urol"},{"key":"6604_CR12","unstructured":"Higgins JPT, Thomas J, Chandler J, et al., eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.3. Cochrane; 2022. Available from: https:\/\/training.cochrane.org\/handbook"},{"key":"6604_CR13","unstructured":"PRISMA. PRISMA 2024 statement. Available from: http:\/\/www.prisma-statement.org\/"},{"key":"6604_CR14","unstructured":"Cochrane Methods. Risk of Bias 2 (RoB-2). Cochrane; 2019. Available from: https:\/\/methods.cochrane.org\/risk-bias-2"},{"key":"6604_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jrsm.1411","volume":"11","author":"LA McGuinness","year":"2020","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2020;11:1\u20137. https:\/\/doi.org\/10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"6604_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejogrb.2018.03.038","volume":"224","author":"M Blaganje","year":"2018","unstructured":"Blaganje M, Scepanovic D, Zgur L, Verdenik I, Pajk F, Lukanovic A. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2018;224:153\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"6604_CR17","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/ijgo.15222","volume":"164","author":"BA O\u2019Reilly","year":"2024","unstructured":"O\u2019Reilly BA, Volker V, Christian P, Toozs-Hobson P, Kuhn A, Athanasiou S, et al. Vaginal erbium laser treatment for stress urinary incontinence: a multicenter randomized sham-controlled clinical trial. Int J Gynaecol Obstet. 2024;164(3):1184\u201394.","journal-title":"Int J Gynaecol Obstet"},{"key":"6604_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.70080","author":"C Phillips","year":"2025","unstructured":"Phillips C, Shah G, Gamper M, Kuszka A, Chandrakumaran K, Viereck V. Vaginal erbium laser for the treatment of mild-to-moderate stress urinary incontinence: a multicentre randomized sham-controlled trial. BJOG. 2025. https:\/\/doi.org\/10.1111\/1471-0528.70080","journal-title":"BJOG"},{"key":"6604_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-025-06160-8","author":"LW Yim","year":"2025","unstructured":"Yim LW, Wan OYK, Wong D, et al. Vaginal laser treatment on stress urinary incontinence: a randomized controlled trial. Int Urogynecol J. 2025. https:\/\/doi.org\/10.1007\/s00192-025-06160-8.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"6604_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-025-04400-3","volume":"40","author":"X Wang","year":"2025","unstructured":"Wang X, Zhang Z, Meng L, Xu S, Zheng J, Wang H, et al. Efficacy and safety of non-ablative Er:YAG laser for mild to moderate stress urinary incontinence: a prospective, multicenter, randomized, sham-controlled clinical trial. Lasers Med Sci. 2025;40(1):195. https:\/\/doi.org\/10.1007\/s10103-025-04400-3.","journal-title":"Lasers Med Sci"},{"issue":"6","key":"6604_CR21","doi-asserted-by":"publisher","first-page":"541.e1","DOI":"10.1016\/j.ajog.2024.11.021","volume":"232","author":"P Lee","year":"2025","unstructured":"Lee P, Perruzza D, Edell H, Jarvi S, Kim K, Sultana R, et al. Double-blind randomized controlled trial of Er:YAG vaginal laser for treating female stress urinary incontinence. Am J Obstet Gynecol. 2025;232(6):541.e1-541.e12. https:\/\/doi.org\/10.1016\/j.ajog.2024.11.021","journal-title":"Am J Obstet Gynecol"},{"key":"6604_CR22","doi-asserted-by":"crossref","unstructured":"Tu L, Laviolette-Brassard M, Lavoie H, Prince M, Elterman D. Pilot single-masked randomized three-arm parallel study assessing tolerability, safety, and efficacy of intraurethral\/intravaginal 2940 nm Er:YAG laser treatment for stress urinary incontinence\u2014preliminary results. ICS Abstract (#60); 2023.","DOI":"10.1016\/j.cont.2023.100778"},{"issue":"3","key":"6604_CR23","doi-asserted-by":"publisher","first-page":"473.e1","DOI":"10.1016\/j.ajog.2022.05.054","volume":"227","author":"JW Alexander","year":"2022","unstructured":"Alexander JW, Karjalainen P, Ow LL, Kulkarni M, Lee JK, Karjalainen T, et al. CO2 surgical laser for treatment of stress urinary incontinence in women: a randomized controlled trial. Am J Obstet Gynecol. 2022;227(3):473.e1-473.e12. https:\/\/doi.org\/10.1016\/j.ajog.2022.05.054.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"6604_CR24","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1007\/s00192-023-05655-6","volume":"34","author":"T Temtanakitpaisan","year":"2023","unstructured":"Temtanakitpaisan T, Chaovisitsaree S, Buppasiri P. Fractional CO2 laser treatment for women with stress-predominant urinary incontinence: a randomized controlled trial. Int Urogynecol J. 2023;34(11):2827\u201332.","journal-title":"Int Urogynecol J"},{"issue":"12","key":"6604_CR25","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1007\/s00192-022-05091-y","volume":"33","author":"AS Seki","year":"2022","unstructured":"Seki AS, Bianchi-Ferraro AMHM, Fonseca ESM, Sartori MGF, Gir\u00e3o MJBC, Jarmy-Di Bella ZIK. CO2 laser and radiofrequency compared to sham control for stress urinary incontinence (LARF study arm 3): a randomized controlled trial. Int Urogynecol J. 2022;33(12):3535\u201342. https:\/\/doi.org\/10.1007\/s00192-022-05091-y.","journal-title":"Int Urogynecol J"},{"key":"6604_CR26","unstructured":"National Institute for Health and Care Excellence (NICE). IPG696: Transvaginal laser therapy for stress urinary incontinence in women. 2024. Available from: https:\/\/www.nice.org.uk\/guidance\/ipg696"},{"key":"6604_CR27","unstructured":"Harding CK, Lapitan MC, Arlandis S, B\u00f8 K, Cobussen-Boekhorst H, Costantini E, et al. EAU Guidelines on Non-neurogenic Female LUTS. Eur Assoc Urol; 2025. Available from: https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Non-neurogenic-Female-LUTS-2025.pdf"},{"issue":"12","key":"6604_CR28","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1111\/1471-0528.17195","volume":"129","author":"C Phillips","year":"2022","unstructured":"Phillips C, Hillard T, Salvatore S, Cardozo L, Toozs-Hobson P, Royal College of Obstetricians and Gynaecologists. Laser treatment for GSM: scientific impact paper no. 72. BJOG. 2022;129(12):e89-94.","journal-title":"BJOG"},{"issue":"11","key":"6604_CR29","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/1471-0528.16273","volume":"127","author":"K Mackova","year":"2020","unstructured":"Mackova K, Van Daele L, Page AS, Geraerts I, Krofta L, Deprest J. Laser therapy for urinary incontinence and pelvic organ prolapse: a systematic review. BJOG. 2020;127(11):1338\u201346.","journal-title":"BJOG"},{"key":"6604_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2025.108658","volume":"199","author":"HB Sigurdard\u00f3ttir","year":"2025","unstructured":"Sigurdard\u00f3ttir HB, Kirschner B, Obel J, Aziz M, Stenz CB, Schroll JB. Vaginal CO2 laser treatment for stress urinary incontinence: a randomized controlled trial. Maturitas. 2025;199:108658.","journal-title":"Maturitas"},{"issue":"7","key":"6604_CR31","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/nau.25244","volume":"42","author":"LC da Fonseca","year":"2023","unstructured":"da Fonseca LC, Giarreta FBA, Peterson TV, Locali PKM, Baracat EC, Ferreira EAG, et al. A randomized trial comparing vaginal laser therapy and pelvic floor physical therapy for treating women with stress urinary incontinence. Neurourol Urodyn. 2023;42(7):1445\u201354.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"6604_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/SPV.0000000000001516","volume":"31","author":"SC Rocha-Rangel","year":"2025","unstructured":"Rocha-Rangel SC, Pereira GMV, Juliato CRT, Brito LGO. Laser and pelvic floor muscle training for urinary incontinence: a randomized clinical trial. Urogynecology. 2025;31(6):627\u201335.","journal-title":"Urogynecology"},{"issue":"6","key":"6604_CR33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00192-025-06091-4","volume":"36","author":"AS Page","year":"2025","unstructured":"Page AS, Borowski E, Bauters E, Housmans S, Van der Aa F, Deprest J. Vaginal erbium laser versus pelvic floor muscle training for stress urinary incontinence: a randomized controlled trial. Int Urogynecol J. 2025;36(6):1265\u201372.","journal-title":"Int Urogynecol J"},{"key":"6604_CR34","unstructured":"ClinicalTrials.gov. NCT06559423. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06559423"},{"issue":"7","key":"6604_CR35","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/nau.70096","volume":"44","author":"ALB Lunardi","year":"2025","unstructured":"Lunardi ALB, Juliato CRT, Slongo H, Machado HC, Riccetto CLZ. Stress urinary incontinence treatment with microablative radiofrequency, pelvic floor muscle training, or both: a randomized controlled trial. Neurourol Urodyn. 2025;44(7):1412\u201324.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"6604_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/13697137.2018.1436538","volume":"21","author":"M Gambacciani","year":"2018","unstructured":"Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M. Long-term effects of vaginal erbium laser in the treatment of GSM. Climacteric. 2018;21(2):148\u201352.","journal-title":"Climacteric"},{"issue":"8","key":"6604_CR37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/lsm.23084","volume":"51","author":"J Ahluwalia","year":"2019","unstructured":"Ahluwalia J, Avram MM, Ortiz AE. Lasers and energy-based devices marketed for vaginal rejuvenation: a MAUDE database analysis. Lasers Surg Med. 2019;51(8):671\u20137.","journal-title":"Lasers Surg Med"},{"issue":"Suppl 1","key":"6604_CR38","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1080\/13697137.2020.1813098","volume":"23","author":"M Gambacciani","year":"2020","unstructured":"Gambacciani M, Cervigni M, Gaspar A, Novakov Mikic A, Gaviria J, Koron N, et al. Safety of vaginal erbium laser: a review of 113,000 patients treated in the past 8 years. Climacteric. 2020;23(Suppl 1):S28-32.","journal-title":"Climacteric"},{"key":"6604_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.maturitas.2017.07.007","volume":"104","author":"S Athanasiou","year":"2017","unstructured":"Athanasiou S, Pitsouni E, Falagas ME, Salvatore S, Grigoriadis T. CO2 laser for genitourinary syndrome of menopause: how many sessions? Maturitas. 2017;104:24\u20138.","journal-title":"Maturitas"},{"issue":"4","key":"6604_CR40","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s10103-021-03474-z","volume":"37","author":"A Gaspar","year":"2022","unstructured":"Gaspar A, Koron N, Silva J, Brandi H. Vaginal erbium laser for stress urinary incontinence: optimization of treatment regimen for sustained long-term effect. Lasers Med Sci. 2022;37(4):2157\u201364.","journal-title":"Lasers Med Sci"},{"issue":"12","key":"6604_CR41","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1007\/s00192-022-05103-x","volume":"33","author":"R Lauterbach","year":"2022","unstructured":"Lauterbach R, Aharoni S, Justman N, Farago N, Gruenwald I, Lowenstein L. Efficacy and safety of a single maintenance laser treatment for stress urinary incontinence: a double-blinded randomized controlled trial. Int Urogynecol J. 2022;33(12):3499\u2013504.","journal-title":"Int Urogynecol J"},{"key":"6604_CR42","doi-asserted-by":"publisher","unstructured":"Seki AS, de Mello Bianchi-Ferraro AMH, Bonetti TCS et al. How long does urinary continence last after treatment with intravaginal CO2 laser and microablative radiofrequency? A four-year follow-up of a multi-arm randomized clinical trial (LARF-arm3). Int Urogynecol J. 2025 Oct;36(10):1971\u20131978. https:\/\/doi.org\/10.1007\/s00192-025-06076-3.\u00a0","DOI":"10.1007\/s00192-025-06076-3"},{"key":"6604_CR43","doi-asserted-by":"crossref","unstructured":"Lu Y, et al. PRP combined with fractional CO2 laser for stress urinary incontinence: randomized controlled trial. Int Urogynecol J. 2025. https:\/\/doi.org\/10.1007\/s00192-025-06292-x","DOI":"10.1007\/s00192-025-06292-x"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06604-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-026-06604-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06604-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:36:00Z","timestamp":1791466560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-026-06604-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["6604"],"URL":"https:\/\/doi.org\/10.1007\/s00192-026-06604-9","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required due to the nature of the study design.Study protocol registration in the International Prospective Register of Systematic Reviews (PROSPERO) database. No. CRD42023423833, 30 June 2023.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DL: speaker honoraria from FotonaCP: Research and speaker honoraria from FotonaGS and MM: none","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}